IR
TMO icon

Invictus RG’s Thermo Fisher Scientific TMO Stock Holding History

Invictus RG’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,981
Closed -$409K – 306
2018
Q1 		$409K Buy
+1,981
New +$416K 0.27% 68

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invictus RG's TMO Position: Q2 2018 in Review

Invictus RG sold out of Thermo Fisher Scientific (TMO) in Q2 2018, closing a stake of 1,981 shares — an estimated $409K sold.

Invictus RG first reported a position in TMO in Q1 2018 and held it in 1 quarter. The position peaked at $409K in Q1 2018. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

  • Invictus RG reported no remaining Thermo Fisher Scientific position as of Q2 2018 after selling out during the quarter.
  • Invictus RG sold 1,981 Thermo Fisher Scientific shares in Q2 2018, an estimated $409K.
  • Invictus RG first reported a position in Thermo Fisher Scientific in Q1 2018 and held it in 1 quarter.
  • Invictus RG's Thermo Fisher Scientific position peaked at $409K in Q1 2018.
  • 1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Invictus RG's 13F filing for Q2 2018, filed 13 Aug 2018.